RecruitingPhase 4NCT07065734
NEgative prEssure Wound Therapy in Renal Transplant
NEgative prEssure Wound Therapy in Renal Transplant - NEWER Trial
Sponsor
Centro Hospitalar De São João, E.P.E.
Enrollment
150 participants
Start Date
Jan 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This is a prospective study involving patients undergoing open renal transplant. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- All patients submitted to kidney transplant
Exclusion Criteria1
- Pediatric patients, those requiring surgical reinterventions within the first 90 days postoperative, patients allergic to NPWT components, orthotopic transplant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICENWPT group
Patients submitted to negative pressure wound therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07065734
Related Trials
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
NCT063372926 locations
Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation
NCT062881521 location
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
NCT031757182 locations
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT0734949816 locations
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
NCT071971641 location